These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9046687)

  • 21. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 22. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
    Sharkey-Mathis PK; Velez J; Fetchick R; Graybill JR
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):809-19. PubMed ID: 8389850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of blastomycosis.
    Bradsher RW
    Semin Respir Infect; 1997 Sep; 12(3):263-7. PubMed ID: 9313298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 25. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antifungal agents.
    Lesher JL
    Dermatol Clin; 1992 Oct; 10(4):799-805. PubMed ID: 1327600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
    Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
    Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
    [No Abstract]   [Full Text] [Related]  

  • 28. Histoplasmosis: update 1998.
    Brooks JT; Wheat LJ
    AIDS Clin Care; 1998 Jan; 10(1):4-5. PubMed ID: 11365076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy for systemic mycosis.
    Polak A
    Infection; 1989; 17(4):203-9. PubMed ID: 2548963
    [No Abstract]   [Full Text] [Related]  

  • 31. Antifungal treatment strategy in leukemia patients.
    Büchner T; Roos N
    Ann Hematol; 1992 Oct; 65(4):153-61. PubMed ID: 1329995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ICAAC update on opportunistic infections.
    D'Amico R
    Posit Aware; 1996; 7(6):16-8. PubMed ID: 11363974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of pulmonary mycoses].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
    [No Abstract]   [Full Text] [Related]  

  • 36. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of systemic candidal infections in the intensive care unit.
    Kam LW; Lin JD
    Am J Health Syst Pharm; 2002 Jan; 59(1):33-41. PubMed ID: 11813465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
    Gøtzsche PC; Johansen HK
    BMJ; 1997 Apr; 314(7089):1238-44. PubMed ID: 9154027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.